SERUM ANTI-STREPTOLYSIN O TITERS AMONG PATIENTS WITH ACUTE KIDNEY INJURY: A CROSS-SECTIONAL STUDY

ABSTRACT:Background: Renal failure is a major clinical problem with diverse etiologies. Among the possible related conditions, infection-associated renal injury may be accompanied by evidence of previous streptococcal exposure. Anti-streptolysin O (ASO) is a serological marker that can support the diagnosis of recent or previous group A Streptococcus infection, particularly in patients with suspected post-streptococcal disease. Objective: The objective was to determine the proportion of patients with acute kidney injury (AKI) who had elevated serum anti-streptolysin O (ASO) titers and to describe the distribution of elevated ASO titers across age groups. Patients and Methods: This cross-sectional study conducted at Al-Diwaniyah Teaching Hospital in Al-Diwaniyah Governorate during the period 4 July 2020 to 30 January 2021. All 98 patients enrolled had acute kidney injury (AKI), diagnosed clinically by the treating nephrologist based on standard criteria used at the study hospital. A prospective, direct interviewing and clinical assessment approach was used to gather the data. Blood was drawn under strictly sterile precautions, and serum urea, creatinine and ASO levels were measured. Age specific results of ASO were interpreted with reference to age-specific normal ranges. Results: A total of 98 patients aged 1–73 years were included. Males constituted 57 patients (58.2%), while females constituted 41 patients (41.8%). Elevated ASO titers were detected in 5 patients (5.1%), whereas 93 patients (94.9%) had ASO titers within the age-specific reference range. Elevated ASO titers were found in patients aged 2-3.9 years (2 cases), 4-5.9 years (1 case), 40-59.9 years (1 case), and ≥60 years (1 case). Conclusion: Elevated ASO titers were uncommon among patients with acute kidney injury, occurring in only 5.1% of participants. Most patients (94.9%) had ASO titers within age-specific reference ranges. These findings indicate that elevated ASO was infrequent in this AKI population. When elevated, ASO titers should be interpreted in the context of age, clinical findings, laboratory data, and the timing of testing. An elevated ASO titer alone does not establish post-streptococcal glomerulonephritis

Authors

Institutions

Publication Details

Journal
Nigerian Journal of Pharmaceutical and Biomedical Research (NJPBR)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24290906
Primary Topic
Streptococcal Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

SERUM ANTI-STREPTOLYSIN O TITERS AMONG PATIENTS WITH ACUTE KIDNEY INJURY: A CROSS-SECTIONAL STUDY

Muhamed Ali Al Kabe, Eman Th. Nadhaif Al-Fatlawy
Nigerian Journal of Pharmaceutical and Biomedical Research (NJPBR)
Streptococcal Infections and Treatments
article

SERUM ANTI-STREPTOLYSIN O TITERS AMONG PATIENTS WITH ACUTE KIDNEY INJURY: A CROSS-SECTIONAL STUDY

Muhamed Ali Al Kabe, Eman Th. Nadhaif Al-Fatlawy
article en

Abstract

ABSTRACT:Background: Renal failure is a major clinical problem with diverse etiologies. Among the possible related conditions, infection-associated renal injury may be accompanied by evidence of previous streptococcal exposure. Anti-streptolysin O (ASO) is a serological marker that can support the diagnosis of recent or previous group A Streptococcus infection, particularly in patients with suspected post-streptococcal disease. Objective: The objective was to determine the proportion of patients with acute kidney injury (AKI) who had elevated serum anti-streptolysin O (ASO) titers and to describe the distribution of elevated ASO titers across age groups. Patients and Methods: This cross-sectional study conducted at Al-Diwaniyah Teaching Hospital in Al-Diwaniyah Governorate during the period 4 July 2020 to 30 January 2021. All 98 patients enrolled had acute kidney injury (AKI), diagnosed clinically by the treating nephrologist based on standard criteria used at the study hospital. A prospective, direct interviewing and clinical assessment approach was used to gather the data. Blood was drawn under strictly sterile precautions, and serum urea, creatinine and ASO levels were measured. Age specific results of ASO were interpreted with reference to age-specific normal ranges. Results: A total of 98 patients aged 1–73 years were included. Males constituted 57 patients (58.2%), while females constituted 41 patients (41.8%). Elevated ASO titers were detected in 5 patients (5.1%), whereas 93 patients (94.9%) had ASO titers within the age-specific reference range. Elevated ASO titers were found in patients aged 2-3.9 years (2 cases), 4-5.9 years (1 case), 40-59.9 years (1 case), and ≥60 years (1 case). Conclusion: Elevated ASO titers were uncommon among patients with acute kidney injury, occurring in only 5.1% of participants. Most patients (94.9%) had ASO titers within age-specific reference ranges. These findings indicate that elevated ASO was infrequent in this AKI population. When elevated, ASO titers should be interpreted in the context of age, clinical findings, laboratory data, and the timing of testing. An elevated ASO titer alone does not establish post-streptococcal glomerulonephritis

Nigerian Journal of Pharmaceutical and Biomedical Research (NJPBR)
University of Wasit (IQ), University of Kufa (IQ)
Good health and well-being
Streptococcal Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon